https://magnifi.com/stocks/ARQT
Arcutis Biotherapeutics Inc (ARQT) | Magnifi
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product...
arcutis biotherapeuticsincarqtmagnifi
https://www.capitoltrades.com/trades/20003796473?page=10
Gil Cisneros bought ARCUTIS BIOTHERAPEUTICS INC (ARQT:US) on 2026-03-03
Gil Cisneros bought $8000 of ARCUTIS BIOTHERAPEUTICS INC (ARQT:US) on 2026-03-03. He filed the trade after 35 days.
arcutis biotherapeuticsgilcisnerosboughtinc
https://valley.labusinessjournal.com/tag/arcutis-biotherapeutics/
Arcutis Biotherapeutics Archives - Inside The Valley | Los Angeles Business Journal
inside the valleyarcutis biotherapeuticslos angelesbusiness journalarchives
https://www.hl.co.uk/shares/shares-search-results/a/arcutis-biotherapeutics-inc-usd0.0001/dividends
Dividend Payments, History & Dates - Arcutis Biotherapeutics Inc (ARQT)
View Arcutis Biotherapeutics Inc (ARQT) dividend dates and history including final, interim and special dividends. Plus growth, cover and dividend yield.
dividend paymentsarcutis biotherapeuticshistorydatesinc
https://click.markets/symbol/arqt
Arcutis Biotherapeutics Inc (ARQT) IPO | IPO Calendar
Arcutis Biotherapeutics Inc (ARQT) IPO. Public offering date, price, news, and more for Arcutis Biotherapeutics Inc.
arcutis biotherapeuticsipo calendarincarqt
https://stockhouse.com/companies/bullboard?symbol=arqt
NDAQ:ARQT | Stock Discussion | Arcutis Biotherapeutics Inc
Get stock insights, analysis and discussion about Arcutis Biotherapeutics Inc (NDAQ:ARQT). Join the ARQT discussion on Canada's largest online investor...
arcutis biotherapeuticsndaqarqtstockdiscussion
https://www.biospace.com/arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4-august-04-2023
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - August 04,...
Aug 7, 2023 - Arcutis Biotherapeutics, Inc., an early commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, reported...
arcutis biotherapeuticsreportsgrantsnasdaqlisting
https://www.insidermonkey.com/blog/arcutis-biotherapeutics-inc-nasdaqarqt-q1-2025-earnings-call-transcript-1527837/
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Q1 2025 Earnings Call Transcript - Insider Monkey
Operator: Good day and welcome to Arcutis Biotherapeutics' 2025 First Quarter Financial Results Conference Call. At this time, all participants are in a...
earnings call transcriptarcutis biotherapeuticsincnasdaqarqt
https://www.benzinga.com/trading-ideas/movers/23/08/33968667/12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's Intraday Session - Arcutis Biotherapeutics (NASDAQ:ARQT),...
health caremoving inarcutis biotherapeuticsstocksmonday
https://www.cmcmarkets.com/en-gb/instruments/arcutis-biotherapeutics-inc
Arcutis Biotherapeutics Inc | CMC Markets
See the latest Arcutis Biotherapeutics Inc price and client sentiment. View the current price trend and analyse the historical price charts.
arcutis biotherapeuticscmc marketsinc
https://menafn.com/1109758542/Arcutis-Biotherapeutics-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635C4
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4). WESTLAKE VILLAGE, Calif., July 03, 2025 (GLOBE NEWSWIRE) -- Arcutis...
arcutis biotherapeuticsreportsgrantsnasdaqlisting